Abiomed anuncia receita de US$ 132,5 milhões para o T1 do AF 2018, aumento de 29% em relação ao ano anterior
July 28, 2017 09:35 ET
|
Abiomed
DANVERS, Mass., July 28, 2017 (GLOBE NEWSWIRE) -- A Abiomed, Inc. (NASDAQ:ABMD), provedora líder de tecnologias inovadoras de suporte cardíaco, comunicou hoje a receita do primeiro trimestre do ano...
Abiomed宣佈2018會計年度第1季營收1.325億美元，較去年成長29%
July 28, 2017 09:35 ET
|
Abiomed
麻州丹弗斯, July 28, 2017 (GLOBE NEWSWIRE) -- 流的劃時代心臟保健科技供應商Abiomed, Inc.（Nasdaq:...
Abiomed Announces Q1 FY 2018 Revenue of $132.5 Million, Up 29% Over Prior Year
July 27, 2017 07:00 ET
|
Abiomed
DANVERS, Mass., July 27, 2017 (GLOBE NEWSWIRE) -- Abiomed, Inc. (NASDAQ:ABMD), a leading provider of breakthrough heart support technologies, today reported first quarter fiscal 2018 revenue of...
Abiomed First Quarter Fiscal 2018 Earnings and Conference Call Notification
July 06, 2017 07:00 ET
|
Abiomed
DANVERS, Mass., July 06, 2017 (GLOBE NEWSWIRE) -- Abiomed, Inc. (NASDAQ:ABMD) announced that on Thursday, July 27, 2017, the Company will release financial results for the first quarter of fiscal...
New Study with Abiomed’s Impella 2.5® Heart Pump Demonstrates Potential Survival with Pre-PCI Insertion in Heart Attacks with the Left Main Coronary Artery
June 30, 2017 08:04 ET
|
Abiomed
DANVERS, Mass., June 30, 2017 (GLOBE NEWSWIRE) -- Abiomed, Inc. (NASDAQ:ABMD), a leading provider of breakthrough heart support and recovery technologies, announced today the recent publication of a...
Heart Recovery Patients Visit Capitol Hill to Advocate for Lifesaving Cardiovascular Technology
June 09, 2017 08:07 ET
|
Abiomed
WASHINGTON, June 09, 2017 (GLOBE NEWSWIRE) -- Nineteen patients who benefitted from treatment with Abiomed’s Impella heart pumps traveled to Washington, D.C. on June 8, 2017, to meet with elected...
Abiomed to Present at the Jefferies Healthcare Conference
May 30, 2017 08:00 ET
|
Abiomed
DANVERS, Mass., May 30, 2017 (GLOBE NEWSWIRE) -- Abiomed, Inc. (NASDAQ:ABMD), a leading provider of breakthrough heart support technologies, today announced that Michael R. Minogue, Chairman,...
Abiomed Introduces 3rd Generation Impella CP® Heart Pumps at SCAI 2017
May 09, 2017 09:33 ET
|
Abiomed
DANVERS, Mass., May 09, 2017 (GLOBE NEWSWIRE) -- Abiomed, Inc. (NASDAQ:ABMD), a leading provider of breakthrough heart support and recovery technologies, announced the debut of the 3rd Generation...
Abiomed Mengumumkan Pendapatan Kuartal Ke-4 TF 2017 sebesar $124,7 Juta, Naik 33% dari Tahun Sebelumnya dan Total Pendapatan Tahunan sebesar $445,3 Juta, Naik 35% dari Tahun Sebelumnya
May 08, 2017 10:44 ET
|
Abiomed
DANVERS, Mass., May 08, 2017 (GLOBE NEWSWIRE) -- Abiomed, Inc. (NASDAQ:ABMD), penyedia utama untuk teknologi dukungan jantung tingkat lanjut hari ini melaporkan pendapatan fiskal tahun 2017 kuartal...
Abiomed ประกาศรายได้ไตรมาสที่ 4 ปีงบประมาณ 2560 จำนวน 124.7 ล้านดอลลาร์สหรัฐ เพิ่มขึ้นร้อยละ 33 จากปีก่อนและรายได้รวมที่ 445.3 ล้านดอลลาร์สหรัฐ เพิ่มขึ้นร้อยละ 35 เมื่อเทียบกับปีที่ผ่านมา
May 08, 2017 10:44 ET
|
Abiomed
DANVERS, Mass., May 08, 2017 (GLOBE NEWSWIRE) -- Abiomed, Inc. (NASDAQ:ABMD) ผู้ให้บริการชั้นนำด้านเทคโนโลยีอันก้าวหน้าในด้านการสนับสนุนหัวใจได้รายงานในวันนี้เกี่ยวกับรายได้ประจำไตรมาสที่ 4...